April 4, 2018

Agilent and BioTek Join Forces to Create an Integrated Metabolic Analysis and Imaging Platform

SANTA CLARA, Calif. & WINOOSKI, Vt.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) and BioTek Instruments, Inc. today announced a new, integrated solution that combines cellular metabolic analysis and imaging technologies. The optimized solution integrates the Agilent Seahorse XFe96/XFe24 Analyzers with the BioTek Cytation 1 Cell Imaging Multi-Mode Reader. This solution creates a standardized approach for comparing XF data sets, improving assay workflow, embedding images into WAVE softwa

Leave Comment

Your Name *
Your Email *
Your Website
Comment *